![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 38/17 | |
A61P 37/00 |
(11) | Number of the document | 3229827 |
(13) | Kind of document | T |
(96) | European patent application number | 15885769.8 |
Date of filing the European patent application | 2015-12-12 | |
(97) | Date of publication of the European application | 2017-10-18 |
(45) | Date of publication and mention of the grant of the patent | 2019-09-04 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/EP2015/079395 |
Date | 2015-12-12 |
(87) | Number | WO 2016/192819 |
Date | 2016-12-08 |
(30) | Number | Date | Country code |
201462091379 P | 2014-12-12 | US |
(72) |
MULLER, Sylviane, FR
ZIMMER, Robert H., FR
BRIAND, Jean-Paul, FR
|
(73) |
ImmuPharma France SA,
5, rue du Rhōne, 68100 Mulhouse,
FR
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, 3, Rue Michel-Ange, 75794 Paris, FR |
(54) | MODIFIED PEPTIDES AND THEIR USE FOR TREATING CHRONIC INFLAMMATORY DISEASES |
MODIFIED PEPTIDES AND THEIR USE FOR TREATING CHRONIC INFLAMMATORY DISEASES |